These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 30672142)
41. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Moore AS; Holzbaur EL Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3349-58. PubMed ID: 27247382 [TBL] [Abstract][Full Text] [Related]
42. A glaucoma- and ALS-associated mutant of OPTN induces neuronal cell death dependent on Tbk1 activity, autophagy and ER stress. Medchalmi S; Tare P; Sayyad Z; Swarup G FEBS J; 2021 Aug; 288(15):4576-4595. PubMed ID: 33548116 [TBL] [Abstract][Full Text] [Related]
43. Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Li F; Xie X; Wang Y; Liu J; Cheng X; Guo Y; Gong Y; Hu S; Pan L Nat Commun; 2016 Sep; 7():12708. PubMed ID: 27620379 [TBL] [Abstract][Full Text] [Related]
44. TBK1 variants in Chinese patients with amyotrophic lateral sclerosis. Liu X; He J; Chen L; Zhang N; Tang L; Liu X; Ma Y; Fan D Neurobiol Aging; 2021 Jan; 97():149.e9-149.e15. PubMed ID: 32893041 [TBL] [Abstract][Full Text] [Related]
45. A Glaucoma-Associated Variant of Optineurin, M98K, Activates Tbk1 to Enhance Autophagosome Formation and Retinal Cell Death Dependent on Ser177 Phosphorylation of Optineurin. Sirohi K; Kumari A; Radha V; Swarup G PLoS One; 2015; 10(9):e0138289. PubMed ID: 26376340 [TBL] [Abstract][Full Text] [Related]
46. Frustration analysis of TBK1 missense mutations reported in ALS/FTD and cancer patients. Khatoon F; Kumar V; Anjum F; Shafie A; Adnan M; Hassan MI 3 Biotech; 2022 Aug; 12(8):174. PubMed ID: 35845111 [TBL] [Abstract][Full Text] [Related]
47. TBK1 haploinsufficiency in ALS and FTD compromises membrane trafficking. Lu Y; Almeida S; Gao FB Acta Neuropathol; 2021 Jul; 142(1):217-221. PubMed ID: 34081168 [No Abstract] [Full Text] [Related]
49. UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway. Chen T; Zhang W; Huang B; Chen X; Huang C Cells; 2020 May; 9(5):. PubMed ID: 32413959 [TBL] [Abstract][Full Text] [Related]
50. Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation. Parvizi T; Klotz S; Keritam O; Caliskan H; Imhof S; König T; Haider L; Traub-Weidinger T; Wagner M; Brunet T; Brugger M; Zimprich A; Rath J; Stögmann E; Gelpi E; Cetin H Ann Clin Transl Neurol; 2024 Jun; 11(6):1579-1589. PubMed ID: 38689506 [TBL] [Abstract][Full Text] [Related]
52. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. Morton S; Hesson L; Peggie M; Cohen P FEBS Lett; 2008 Mar; 582(6):997-1002. PubMed ID: 18307994 [TBL] [Abstract][Full Text] [Related]
54. Genetic and functional analysis of TBK1 variants in Korean patients with sporadic amyotrophic lateral sclerosis. Kim YE; Oh KW; Noh MY; Nahm M; Park J; Lim SM; Jang JH; Cho EH; Ki CS; Lee S; Kim SH Neurobiol Aging; 2017 Feb; 50():170.e1-170.e6. PubMed ID: 27939697 [TBL] [Abstract][Full Text] [Related]
55. CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis. Dobson-Stone C; Hallupp M; Shahheydari H; Ragagnin AMG; Chatterton Z; Carew-Jones F; Shepherd CE; Stefen H; Paric E; Fath T; Thompson EM; Blumbergs P; Short CL; Field CD; Panegyres PK; Hecker J; Nicholson G; Shaw AD; Fullerton JM; Luty AA; Schofield PR; Brooks WS; Rajan N; Bennett MF; Bahlo M; Landers JE; Piguet O; Hodges JR; Halliday GM; Topp SD; Smith BN; Shaw CE; McCann E; Fifita JA; Williams KL; Atkin JD; Blair IP; Kwok JB Brain; 2020 Mar; 143(3):783-799. PubMed ID: 32185393 [TBL] [Abstract][Full Text] [Related]
56. One family, one gene and three phenotypes: A novel VCP (valosin-containing protein) mutation associated with myopathy with rimmed vacuoles, amyotrophic lateral sclerosis and frontotemporal dementia. Abrahao A; Abath Neto O; Kok F; Zanoteli E; Santos B; Pinto WB; Barsottini OG; Oliveira AS; Pedroso JL J Neurol Sci; 2016 Sep; 368():352-8. PubMed ID: 27538664 [TBL] [Abstract][Full Text] [Related]
57. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. Devenney E; Hornberger M; Irish M; Mioshi E; Burrell J; Tan R; Kiernan MC; Hodges JR JAMA Neurol; 2014 Mar; 71(3):331-9. PubMed ID: 24445580 [TBL] [Abstract][Full Text] [Related]
58. Pozzi L; Valenza F; Mosca L; Dal Mas A; Domi T; Romano A; Tarlarini C; Falzone YM; Tremolizzo L; Sorarù G; Cerri F; Ferraro PM; Basaia S; Agosta F; Fazio R; Comola M; Comi G; Ferrari M; Quattrini A; Lunetta C; Penco S; Bonanomi D; Carrera P; Riva N J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):869-875. PubMed ID: 28822984 [TBL] [Abstract][Full Text] [Related]
59. Novel mutation in optineurin causing aggressive ALS+/-frontotemporal dementia. Feng SM; Che CH; Feng SY; Liu CY; Li LY; Li YX; Huang HP; Zou ZY Ann Clin Transl Neurol; 2019 Dec; 6(12):2377-2383. PubMed ID: 31838784 [TBL] [Abstract][Full Text] [Related]